BioMatrix Specialty Pharmacy
BioMatrix Specialty Pharmacy (now operating as LUX Infusion) is a privately held specialty pharmacy and ambulatory infusion platform operating 11+ owned outpatient infusion centers across the US, serving chronic disease and transplant patients in 42 states.
- Company typePrivate
- Founded2015
- HeadquartersPlantation, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
What BioMatrix Specialty Pharmacy does
BioMatrix Specialty Pharmacy, operating as LUX Infusion since April 1, 2026, is a privately held specialty pharmacy and ambulatory infusion services platform headquartered in Plantation, Florida. The company operates a national network of owned and operated outpatient infusion centers providing injectable and IV therapies for patients with chronic conditions, including autoimmune disorders, immune deficiencies, and post-transplant medication regimens. In 2025, the company supported over 800 transplant patients across 42 states with a documented 14-day start-of-care timeline from referral to therapy initiation, alongside an ambulatory infusion footprint spanning 11+ centers across at least five states following a series of acquisitions (LUX Infusion in Alaska, Total Infusion Care in Nevada, First Choice Wellness Centers in the Southeast).
The company's technology stack centers on the Plenful AI-powered workflow automation platform, deployed in September 2025, which automates intake authorization management, fax processing, data extraction, benefit verification, prior authorization submission, and 340B compliance using pharmacy-specialized large language models and intelligent document processing. Reported outcomes include a more than 75% reduction in authorization processing time and a quadrupling of team capacity. The platform integrates into existing pharmacy workflows and is positioned as a core operational partnership rather than an in-house AI build.
BioMatrix generates revenue through two primary streams: ambulatory infusion services delivered via company-owned centers under a professional services billing model, and specialty pharmacy dispensing (notably for transplant pharmaceuticals) under a managed services model. Services are billed through insurance, Medicare, and Medicaid based on contracted payer rates; pricing is not publicly disclosed. Go-to-market is sales-led and built on relationship-based referral networks with transplant programs, rheumatologists, neurologists, and other specialists, supplemented by payer and health system contracts. Leadership includes CEO Kathee Kramm, CFO Joseph Ziegler, and Chief Growth Officer William Nolan; Heidi Ulbrich was promoted to Transplant Services Program Manager in February 2026. The company raised $80M in a 2016 funding round and has executed multiple acquisitions since 2020 (City Drugs, InfuCare, Mylyfe Specialty Pharmacy, LUX Infusion, Total Infusion Care, First Choice Wellness Centers).
BioMatrix Specialty Pharmacy firmographics
Firmographics- Name
- BioMatrix Specialty Pharmacy
- Legal name
- BioMatrix Infusion Pharmacy
- Website
- http://www.biomatrixsprx.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- BioMatrix Specialty Pharmacy (now operating as LUX Infusion) is a privately held specialty pharmacy and ambulatory infusion platform operating 11+ owned outpatient infusion centers across the US, serving chronic disease and transplant patients in 42 states.
- Ownership category
- akta.pro rank
BioMatrix Specialty Pharmacy industry classification
Industry- Product category
- Specialty Pharmacy and Ambulatory Infusion Services
- NAICS
- Other Ambulatory Health Care Services (6219)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Infusion & Home Infusion Pharmacy Services (HLAFALAG)
- akta.pro secondary industries
- Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG), Specialty Injectable & Infusion Therapies (Cross-therapeutic) (HLAIACAO)
Keywords
Where BioMatrix Specialty Pharmacy is headquartered
LocationHeadquarters
- HQ city
- Plantation
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
BioMatrix Specialty Pharmacy business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Ambulatory Infusion Services: Revenue generated from operating outpatient infusion centers providing medication administration services to patients with chronic conditions requiring injectable or infusion therapies
- Specialty Pharmacy Dispensing: Revenue from dispensing specialty medications, including transplant-related pharmaceuticals, with an industry-leading 14-day start of care from referral to therapy initiation
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
BioMatrix Specialty Pharmacy product offering
Product offeringCore offering
BioMatrix Specialty Pharmacy operates a national network of company-owned ambulatory infusion centers and specialty pharmacy services, providing outpatient infusion therapy for chronic conditions (autoimmune disorders, immune deficiencies, biologics) and specialized transplant medication management. Services are accessed via physician and specialist referrals, with payer contracts (insurance, Medicare, Medicaid) covering infusion administration and specialty medication dispensing. Operations are supported by the Plenful AI-powered workflow automation platform that streamlines prior authorization, intake, benefit verification, and 340B compliance.
Product overview
BioMatrix Infusion Pharmacy (rebranded as LUX Infusion as of April 2026) operates a network of infusion centers and specialty pharmacy services across the United States. The core offering is ambulatory infusion therapy services, expanded through multiple strategic acquisitions including LUX Infusion (Pacific Northwest/Alaska), Total Infusion Care (Nevada/western U.S.), and First Choice Wellness Centers (Southeast). The company also runs a Transplant Services Program supporting over 800 patients annually across 42 states. Operations leverage the Plenful AI workflow automation platform for intake authorization management, benefit verification, and 340B compliance, achieving significant efficiency gains. Following the April 2026 rebrand, all locations and services unified under the LUX Infusion name.
Differentiator
Problem solved
Functional benefit
Products and services
- Ambulatory Infusion Services Outpatient infusion therapy services providing administration of specialty injectable and IV medications (immunoglobulin, biologics) for patients with chronic conditions including autoimmune disorders and immune deficiencies. Services are accessed via specialist referrals at community-based infusion centers.
- Transplant Services Program Specialized pharmacy program supporting transplant patients with medication management, pre- and post-transplant care coordination, and therapy initiation. Coordinates with transplant programs, specialists, and payers across 42 states with an industry-leading 14-day start of care benchmark.
- Specialty Pharmacy Dispensing Dispensing of specialty pharmaceuticals, including transplant-related medications, supported by Plenful AI workflow automation for intake authorization, prior authorization, benefit verification, and 340B compliance. Achieves 75% processing time reduction and 4x capacity increase.
Quantifiable outcome
- Reduced intake authorization processing time by more than 75% through AI automation
- +3 more outcomes
Companies that use BioMatrix Specialty Pharmacy
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles2 records
BioMatrix Specialty Pharmacy technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability6 records
Feature1 record
BioMatrix Specialty Pharmacy partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- PlenfulcorePlenful provides AI-powered intake authorization management automation to BioMatrix Specialty Infusion Pharmacy. The platform reduces processing time by more than 75% and quadruples team capacity through automated fax processing, data extraction, benefit verification, and prior authorization submission using large language models and intelligent document processing. This technology partnership enables operational efficiency improvements across the company's specialty and infusion pharmacy operations.
Scale indicators6 records
Recent moves7 records
Expansion highlights6 records
BioMatrix Specialty Pharmacy competitors and assessment
Company assessmentDirect peers
- Option Care Health: Largest independent provider of home and alternate-site infusion services in the U.S., with a national footprint and a similar specialty pharmacy + infusion model focused on chronic and complex therapies — directly comparable to BioMatrix's ambulatory infusion and specialty pharmacy offering.
- Soleo Health: Specialty infusion pharmacy and home infusion services provider focused on complex conditions including immunoglobulin therapy, biologics, and chronic disease management — overlapping with BioMatrix's ambulatory infusion and specialty pharmacy product mix.
- Amerita: Specialty infusion pharmacy serving patients with chronic and complex conditions across multiple states, with services spanning infusion, injectable, and enteral therapies — directly comparable business model and patient population to BioMatrix.
- IVX Health: Outpatient infusion center network providing IV therapy for chronic conditions in a community-based setting — directly comparable physical infusion center model and patient experience to BioMatrix's infusion center operations.
- Vivo Infusion: Outpatient infusion therapy provider operating a network of community-based infusion centers across multiple states — directly comparable site-of-care strategy and specialty therapy focus.
- Vital Care Infusion Services: Franchise-based ambulatory infusion network providing specialty infusion therapies across the U.S. — directly comparable community infusion center model serving similar chronic disease populations.
- Nufactor: Specialty infusion pharmacy focused on hemophilia, immune deficiencies, and complex chronic conditions — overlapping with BioMatrix's specialty pharmacy dispensing for complex and biologic therapies.
Broad incumbents
- Accredo (Express Scripts): Specialty pharmacy arm of one of the largest PBMs in the U.S., offering nationwide dispensing of specialty and biologic medications including transplant and infusion therapies — a large incumbent with overlapping capabilities but broader portfolio.
- CVS Specialty (Caremark): Specialty pharmacy division of CVS Health, providing nationwide specialty medication dispensing and infusion services through a vertically integrated payer/PBM/retail network — broad incumbent competing for the same specialty therapy prescriptions.
- Walgreens Specialty Pharmacy: Specialty pharmacy operations of one of the largest U.S. pharmacy retailers, dispensing specialty and biologic medications across a national footprint — broad incumbent with overlapping specialty pharmacy capabilities.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
BioMatrix Specialty Pharmacy social profiles
Digital presenceBioMatrix Specialty Pharmacy financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioMatrix Specialty Pharmacy leadership team
Management profileNumber of profiles
Profiles5 records
BioMatrix Specialty Pharmacy subsidiaries and ownership
Company hierarchySubsidiaries3 records
BioMatrix Specialty Pharmacy funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioMatrix Specialty Pharmacy M&A and investment
M&A and investmentM&A6 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioMatrix Specialty Pharmacy
What does BioMatrix Specialty Pharmacy do?
BioMatrix Specialty Pharmacy operates a national network of company-owned ambulatory infusion centers and specialty pharmacy services, providing outpatient infusion therapy for chronic conditions (autoimmune disorders, immune deficiencies, biologics) and specialized transplant medication management. Services are accessed via physician and specialist referrals, with payer contracts (insurance, Medicare, Medicaid) covering infusion administration and specialty medication dispensing. Operations are supported by the Plenful AI-powered workflow automation platform that streamlines prior authorization, intake, benefit verification, and 340B compliance.
Is BioMatrix Specialty Pharmacy a public or private company?
BioMatrix Specialty Pharmacy is a private company. It is classified as unknown and is currently operating.
When was BioMatrix Specialty Pharmacy founded?
BioMatrix Specialty Pharmacy was founded in 2015. It employs 251 to 500 people.
Where is BioMatrix Specialty Pharmacy based?
BioMatrix Specialty Pharmacy is headquartered in Plantation, United States, in the North America region.
How does BioMatrix Specialty Pharmacy make money?
Two revenue lines are on record. Ambulatory Infusion Services are the primary driver. The others are specialty Pharmacy Dispensing.
Who are BioMatrix Specialty Pharmacy's main competitors?
Direct peers on record are Option Care Health, Soleo Health, Amerita, IVX Health, Vivo Infusion, Vital Care Infusion Services and Nufactor. Broad incumbents are Accredo (Express Scripts), CVS Specialty (Caremark) and Walgreens Specialty Pharmacy.
Does BioMatrix Specialty Pharmacy have an API?
No public API is recorded for BioMatrix Specialty Pharmacy.
What industry is BioMatrix Specialty Pharmacy in?
BioMatrix Specialty Pharmacy's product category is Specialty Pharmacy and Ambulatory Infusion Services. Its primary akta.pro industry code is HLAFALAG, Infusion & Home Infusion Pharmacy Services, with a secondary code of HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms. Its NAICS code is 6219 and its SIC code is 8093.